Zongertinib

  • Compound: N-[1-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]piperidin-4-yl]prop-2-enamide
  • Description: Receptor tyrosine protien kinase erbB-2 inhibitor.
  • Brand Name:
  • Code(s): BI 1810631, BI-1810631, BI1810631
  • Approved:
  • Kinase Class: None
  • Inhibitor Type: None
  • Literature (PubMed): 0
  • Target(s):
  • Disease(s):

Identifiers (3)

  • International Nonproprietary Name: zongertinib [INN] (Source: PubChem)
  • KEGG Drug ID: D12879 (Source: PubChem)
  • United States Adopted Name: ZONGERTINIB [USAN] (Source: PubChem)

    • Sources: PubChem (3)